Circulating endothelial cells are elevated in patients with type 1 diabetes mellitus

European Journal of Endocrinology

Volumn 162, Issue 4, 2010, Pages 711-717

  Asicioglu, Ebru ^a   Yavuz, Dilek Gogas ^a   Koc, Mehmet ^a   Ozben, Beste ^a   Yazici, Dilek ^a   Deyneli, Oguzhan ^a   Akalin, Sema ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE; GLUCOSE; GLUTATHIONE; HEMOGLOBIN A1C; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; BLOOD VESSEL INJURY; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; FLUORESCENCE MICROSCOPY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; VASODILATATION;

ADULT; ARYLDIALKYLPHOSPHATASE; BRACHIAL ARTERY; CELL COUNT; DIABETES MELLITUS, TYPE 1; ELECTROCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; GLUTATHIONE; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; OXIDATIVE STRESS; STATISTICS, NONPARAMETRIC; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VASODILATION;

EID: 77950334145     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0795     Document Type: Article

References (49)

1. Celermajer DS. Endothelial dysfunction: does it matter? Is it reversible? Journal of the American College of Cardiology 1997 30 325-333.
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001 414 813-820.
3. Swerdlow AJ & Jones ME. Mortality during 25 years of follow-up of a cohort with diabetes. International Journal of Epidemiology 1996 25 1250-1261.
4. Ceriello A, Esposito K, Ihnat M, Thorpe J & Giugliano D. Long-term glycemic control influences the long-lasting effect of hyperglycemia on endothelial function in type 1 diabetes. Journal of Clinical Endocrinology and Metabolism 2009 94 2751-2756.
5. Sibal L, Aldibbiat A, Agarwal SC, Mitchell G, Oates C, Razvi S, Weaver JU, Shaw JA & Home PD. Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria. Diabetologia 2009 52 1464-1473.
6. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK & Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993 88 2510-2516.
7. Meeking DR, Cummings MH, Thorne S, Donald A, Clarkson P, Crook JR, Watts GF & Shaw KM. Endothelial dysfunction in type 2 diabetic subjects with and without microalbuminuria. Diabetic Medicine 1999 16 841-847.
8. Jarvisalo MJ, Raitakari M, Toikka JO, Putto-Laurila A, Rontu R, Laine S, Lehtimäki T, Rönnemaa T, Viikari J & Raitakari OT. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation 2004 109 1750-1755.
9. Clarkson P, Celermajer DS, Donald AE, Sampson M, Sorensen KE, Adams M, Yue DK, Betteridge DJ & Deanfield JE. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. Journal of the American College of Cardiology 1996 28 573-579.
10. Dogra G, Rich L, Stanton K & Watts GF. Endothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria. Diabetologia 2001 44 593-601.
11. Henry RM, Ferreira I, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Kamp O, Bouter LM & Stehouwer CD. Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not: the Hoorn Study. Atherosclerosis 2004 174 49-56.
12. Makimattila S, Liu ML, Vakkilainen J, Schlenzka A, Lahdenpera S, Syvanne M, Mäntysaari M, Summanen P, Bergholm R, Taskinen MR & Yki-Järvinen H. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. Diabetes Care 1999 22 973-981.
13. Giugliano D, Ceriello A & Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996 19 257-267.
14. Stehouwer CD, Lambert J, Donker AJ & van Hinsbergh VW. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovascular Research 1997 34 55-68.
15. Mabley JG & Soriano FG. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic vascular dysfunction. Current Vascular Pharmacology 2005 3 247-252.
16. King GL & Loeken MR. Hyperglycemia-induced oxidative stress in diabetic complications. Histochemistry and Cell Biology 2004 122 333-338.
17. Zou MH, Shi C & Cohen RA. High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 2002 51 198-203.
18. Baumgartner-Parzer SM, Wagner L, Pettermann M, Grillari J, Gessl A & Waldhausl W. High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 1995 44 1323-1327.
19. Lorenzi M, Nordberg JA & Toledo S. High glucose prolongs cell-cycle traversal of cultured human endothelial cells. Diabetes 1987 36 1261-1267.
20. Du X, Stocklauser-Farber K & Rosen P. Generation of reactive oxygen intermediates, activation of NF-kappaB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase? Free Radical Biology & Medicine 1999 27 752-763.
21. Nakao-Hayashi J, Ito H & Kawashima S. An oxidative mechanism is involved in high glucose-induced serum protein modification causing inhibition of endothelial cell proliferation. Atherosclerosis 1992 97 89-95.
22. Khan SS, Solomon MA & McCoy JP Jr. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry. Part B, Clinical Cytometry 2005 64 1-8.
23. Mutin M, Canavy I, Blann A, Bory M, Sampol J & Dignat-George F. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 1999 93 2951-2958.
24. George F, Brouqui P, Boffa MC, Mutin M, Drancourt M, Brisson C, Raoult D & Sampol J. Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever. Blood 1993 82 2109-2116.
25. Percivalle E, Revello MG, Vago L, Morini F & Gerna G. Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement. Journal of Clinical Investigation 1993 92 663-670.
26. Nakatani K, Takeshita S, Tsujimoto H, Kawamura Y, Tokutomi T & Sekine I. Circulating endothelial cells in Kawasaki disease. Clinical and Experimental Immunology 2003 131 536-540.
27. Clancy R, Marder G, Martin V, Belmont HM, Abramson SB & Buyon J. Circulating activated endothelial cells in systemic lupus erythematosus: further evidence for diffuse vasculopathy. Arthritis and Rheumatism 2001 44 1203-1208.
28. Woywodt A, Streiber F, de Groot K, Regelsberger H, Haller H & Haubitz M. Circulating endothelial cells as markers for ANC-Aassociated small-vessel vasculitis. Lancet 2003 361 206-210.
29. McClung JA, Naseer N, Saleem M, Rossi GP, Weiss MB, Abraham NG & Kappas A. Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c. Diabetologia 2005 48 345-350.
30. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr & Roccella EJ. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Journal of the American Medical Association 2003 289 2560-2572.
31. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 106 3143-3421.
32. Woywodt A, Blann AD, Kirsch T, Erdbruegger U, Banzet N, Haubitz M & Dignat-George F. Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol. Journal of Thrombosis and Haemostasis 2006 4 671-677.
33. Yagi K. Assay for blood plasma or serum. Methods in Enzymology 1984 105 328-331.
34. Abbott CA, Mackness MI, Kumar S, Boulton AJ & Durrington PN. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arteriosclerosis, Thrombosis, and Vascular Biology 1995 15 1812-1818.
35. Hu ML. Measurement of protein thiol groups and glutathione in plasma. Methods in Enzymology 1994 233 380-385.
36. Koç M, Bihorac A & Segal MS. Circulating endothelial cells as potential markers of the state of the endothelium in hemodialysis patients. American Journal of Kidney Diseases 2003 42 704-712.
37. Boos CJ, Lane DA, Karpha M, Beevers DG, Haynes R & Lip GY. Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension. Chest 2007 132 1540-1547.
38. Pirro M, Bagaglia F, Paoletti L, Razzi R & Mannarino MR. Hypercholesterolemia-associated endothelial progenitor cell dysfunction. Therapeutic Advances in Cardiovascular Disease 2008 2 329-339.
39. Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, Pietschmann P, Prager R, Schnack C & Schernthaner G. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. American Journal of Medicine 1995 98 469-475.
40. Jain SK & McVie R. Effect of glycemic control, race (white versus black), and duration of diabetes on reduced glutathione content in erythrocytes of diabetic patients. Metabolism 1994 43 306-309.
41. Mackness B, Durrington PN, Boulton AJ, Hine D & Mackness MI. Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls. European Journal of Clinical Investigation 2002 32 259-264.
42. Curcio F & Ceriello A. Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: new insights on the pathophysiological mechanisms of diabetic vascular complications. In Vitro Cellular & Developmental Biology 1992 28 787-790.
43. Taniyama Y & Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 2003 42 1075-1081.
44. Abraham NG, Rezzani R, Rodella L, Kruger A, Taller D, Li Volti G, Goodman AI & Kappas A. Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. American Journal of Physiology. Heart and Circulatory Physiology 2004 287 2468-2477.
45. Woywodt A, Goldberg C, Kirsch T, de Groot K, Erdbruegger U, Haller H & Haubitz M. Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA associated vasculitis. Annals of Rheumatic Disease 2006 65 164-168.
46. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi A & Finkel T. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New England Journal of Medicine 2003 348 593-600.
47. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM & Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circulation Research 2001 89 1-7.
48. Boos CJ, Soor SK, Kang D & Lip GY. Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes. European Heart Journal 2007 28 1092-1101.
49. Koc M, Richards HB, Bihorac A, Ross EA, Schold JD & Segal MS. Circulating endothelial cells are associated with future vascular events in hemodialysis patients. Kidney International 2005 67 1078-1083.